Eva Anzenbacherová - Concepedia

Author

Eva Anzenbacherová

Also Known As

ANZENBACHEROVA, EVA, Anzenbacherova, Eva, Anzenbacherová, Eva, E Anzenbacherova, E Anzenbacherová, E. ANZENBACHEROVÁ, E. Anzenbacherova, E. Anzenbacherová, Eva Anzenbacherova, Eva Anzenbacherová

126

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Palacký University Olomouc Charles University Inserm Czech Academy of Sciences, Institute of Microbiology Czech Academy of Sciences

About

Eva Anzenbacherová is an author at Palacký University Olomouc specializing in medicine, pharmacology, and metabolomics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	31	976
2	Health Sciences	11	12	456
3	Natural Sciences	9	9	197
4	Engineering	2	2	21
5	Public Health	1	1	16

Eva Anzenbacherová

Publications

Citations

H-Index

Page 1

	Year	Citations
Valproic Acid Induces CYP3A4 and MDR1 Gene Expression by Activation of Constitutive Androstane Receptor and Pregnane X Receptor Pathways Lukáš Červený, Lucie Svecova, Eva Anzenbacherová, Drug Metabolism and Disposition	2007	221
Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples. Pavel Anzenbacher, Pavel Souček, Eva Anzenbacherová, PubMed Cyp Enzyme LevelsMolecular BiologyRedox BiologyToxicological MechanismOxidative Stress	1998	150
Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs Pavel Souček, Roman Zuber, Eva Anzenbacherová, BMC Pharmacology	2001	105
Administration of a Probiotic Can Change Drug Pharmacokinetics: Effect of E. coli Nissle 1917 on Amidarone Absorption in Rats Zuzana Matušková, Eva Anzenbacherová, Rostislav Večeřa, PLoS ONE PharmacotherapyProbioticsDrug ResistanceProbioticPharmacological Study	2014	87
JNK inhibitor SP600125 is a partial agonist of human aryl hydrocarbon receptor and induces CYP1A1 and CYP1A2 genes in primary human hepatocytes Zdeněk Dvořák, Radim Vrzal, Pavla Henklová, Biochemical Pharmacology Molecular PhysiologySignal TransductionHepatologyCyp1a2 GenesMedicine	2007	75
Flexibility of human cytochrome P450 enzymes: Molecular dynamics and spectroscopy reveal important function-related variations Tereza Hendrychová, Eva Anzenbacherová, Josef Skopalík, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics BiochemistryNatural SciencesMolecular BiologyEnzyme SpecificityHuman Cytochrome P450	2010	71
Silybin Is Metabolized by Cytochrome P450 2C8 in Vitro Petra Jančová, Eva Anzenbacherová, Barbora Papoušková, Drug Metabolism and Disposition	2007	70
SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes Pavla Henklová, Radim Vrzal, Barbora Papoušková, European Journal of Pharmacology Signal TransductionHepatologySignaling PathwayMolecular PathwayMedicine	2008	65
Azole Antimycotics Differentially Affect Rifampicin-Induced Pregnane X Receptor-Mediated CYP3A4 Gene Expression Lucie Svecova, Radim Vrzal, Ladislav Burýšek, Drug Metabolism and Disposition	2007	56
Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions Stanislav Mičuda, Lucie Mundlova, Eva Anzenbacherová, European Journal of Clinical Pharmacology Inhibitory EffectsBiochemistryMedicineExperimental PharmacologyPharmacotherapy	2004	54

Page 1